Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1485 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Ipsen S.A.. (2/27/13). "Press Release: Ipsen 2012 Financial Results. Full Year 2012 Results Presentation". Paris. 2013-02-27
Cellectis S.A.. (2/25/13). "Press Release: Cellectis Announces Appointment of Pierre Schwich as Group CFO". Paris. 2013-02-25
Neovacs S.A.. (2/15/13). "Press Release: Neovacs Launches €6.3 Million Capital Increase to Finance Clinical Proof-of-Concept for the TNF-Kinoid [Not for USA, Canada, Australia, Italy or Japan]". Paris. 2013-02-15
Theradiag S.A.. (2/15/13). "Press Release: Theradiag Receives CE Mark Approval for Two New Lisa Tracker Monitoring Kits in Theranostics". Croissy-Beaubourg. 2013-02-15
Analytical Pixels Technology S.A.S. (APIX). (2/14/13). "Press Release: APIX Technology Introduces Industry’s First Gas Chromatography Device Based on Silicon Nano-scale Components". Grenoble. 2013-02-14
Vivalis S.A.. (2/14/13). "Press Release: 2012 – A Record Year for New EB66 Cell Line Licensing". Nantes. 2013-02-14
Analytical Pixels Technology S.A.S. (APIX). (2/7/13). "Press Release: APIX Technology Signs a Comprehensive IP Licensing Agreement with CEA-Leti and Caltech. APIX Secures Rights to Industry Leading Nano-scale Sensor Technology". Grenoble. 2013-02-07
Diaxonhit S.A.. (2/6/13). "Press Release: Diaxonhit Is Informed by Allergan that Bristol-Myers Squibb Has Decided to Stop Development of EHT/AGN 001". Paris. 2013-02-06
Clevexel Pharma. (2/1/13). "Press Release: Clevexel Pharma, a Recently Formed Spin-off from Teva, Presents Its Management Team, Strategic Positioning and Mid-term Objectives". Maisons-Alfort, Paris. 2013-02-01
Deinove S.A.. (1/9/13). "Press Release: Emmanuel Petiot Becomes CEO of Deinove. Emmanuel Petiot Was formerly Director of Sales of Novozymes in the United States". Paris. 2013-01-09
Alizé Pharma. (1/3/13). "Press Release: Alizé Pharma Launches the PREMAG Research Program". Lyon. 2013-01-03
Eurofins Scientific. (1/2/13). "Press Release: Eurofins Subsidiary Agrees to Acquire a Further 7% Additional Stake in Cerep S.A.". 2013-01-02
Cellectis S.A.. (12/18/12). "Press Release: Cellectis – an Innovative Anti-cancer Approach. The University College of London and Cellectis Have Signed a Collaboration Agreement to Develop a T-cell Adoptive Immunotherapy to Fight Leukemia". Paris. 2012-12-18
Poxel S.A.. (12/18/12). "Press Release: Poxel Raises €13 Million to Progress Imeglimin Development to Treat Type 2 Diabetes". Lyon. 2012-12-18
Oncodesign S.A.. (12/18/12). "Press Release: Oncodesign and the Laboratory for Neurobiology and Gene Therapy at the KU Leuven Enter into a Research Collaboration for Advancing Drug Discovery Efforts with Ipsen in Parkinson’s Disease". Dijon, Leuven & Par 2012-12-18
Vivalis S.A.. (12/16/12). "Press Release: Proposed Merger of Equals between Vivalis and Intercell. Creation of a European Biotech Leader in Vaccines and Antibodies [Not for Distribution in Australia, Canada, Japan or the United States]". Nantes & Vienna. 2012-12-16
Institut Curie. (12/12/12). "Press Release: Curie-Cancer Funds Its First Selection of 5 Late-stage Projects". Paris. 2012-12-12
Theradiag S.A.. (12/6/12). "Press Release: Success of the Theradiag IPO. €8.2 Million Raised [Not for direct or indirect distribution in the United States, Canada, Australia, Italy or Japan]". Croissy-Beaubourg. 2012-12-06
bioMérieux S.A.. (12/4/12). "Press Release: bioMérieux Opens a Subsidiary in Vietnam, Strengthening Its Footprint in High-growth Southeast Asia". Marcy l’Étoile. 2012-12-04
Advanced Chemistry Development, Inc. (ACD/Labs). (12/3/12). "Press Release: Increasing the Efficiency of Complex By-products Research with ACD/Structure Elucidator". Toronto. 2012-12-03
Ipsogen S.A.. (11/29/12). "Press Release: Ipsogen to Be Renamed Qiagen Marseille on the First of January 2013. Results of the General Assembly of 14 November 2012 – Perspectives for 2013". Marseille. 2012-11-29
Evotec AG. (11/23/12). "Press Release: Evotec Receives CIR (French Research Tax Credit) Accreditation". Hamburg. 2012-11-23
ObeTherapy Biotechnology. (11/22/12). "Press Release: ObeTherapy Announces the Publication of Results Obtained with One of its Lead Compounds on a New Target for the Treatment of Obesity and Type II Diabetes". Paris. 2012-11-22
bioMérieux S.A.. (11/15/12). "Press Release: bioMérieux and Quanterix Sign Strategic Partnership in Ultrasensitive and Multiplex Immunoassays. Quanterix’s Simoa Technology to Be Developed for Diagnostic Applications". Marcy l’Étoile & Lexington, MA. 2012-11-15
Exonhit S.A.. (11/6/12). "Press Release: Exonhit Announces the Upcoming Acquistion of InGen BioSciences, the Leading Independent Distributor of In-vitro Diagnostics in the French Market [Not for distribution in the U.S., Japan, Canada and Australia]". Pa 2012-11-06
Poxel S.A.. (11/5/12). "Press Release: Poxel’s Anti-diabetic Imeglimin Shows Significant Clinical Benefits in Type 2 Diabetes when Added to Sitagliptin. Phase II Study Achieved Primary and Secondary Endpoints". Lyon. 2012-11-05
Ipsen S.A.. (10/29/12). "Press Release: Ipsen’s Third Quarter and First Nine Months 2012 Sales". Paris. 2012-10-29
Sanofi S.A.. (10/25/12). "Press Release: Q3 2012 Business EPS Reflects Patent Expirations. Growth Platforms Reached over 70% of Sales". Paris. 2012-10-25
Biom’Up S.A.. (10/25/12). "Press Release: Biom’Up Raises EUR 6.8 Million". Lyon. 2012-10-25
Theradiag. (10/25/12). "Press Release: Theradiag Announces the Signature of a Partnership Agreement with Sebia for the Development of a New Diagnostic Kit". Paris. 2012-10-25
Nanobiotix. (10/24/12). "Press Release: Resounding Success of the IPO of Nanobiotix, which Has Raised €14.2 Million on the Regulated Market of NYSE Euronext in Paris [restricted]". Paris. 2012-10-24
bioMérieux S.A.. (10/23/12). "Press Release: Business Review for the Nine Months Ended September 30, 2012". Marcy l’Étoile. 2012-10-23
European Science Foundation. (10/19/12). "Press Release: The European Science Foundation’s EMRC Calls for the Adoption of Open Access in Biomedical Sciences. New Report Assesses Open Access in Biomedical Research Across Europe". 2012-10-19
Nanobiotix. (10/11/12). "Press Release: Nanobiotix Launches Its IPO on the on the NYSE Euronext Regulated Market in Paris [restricted]". Paris. 2012-10-11
Novasep S.A.. (10/10/12). "Press Release: Novasep Invests € 30 Million to Build World’s Largest Chromatography Plant for the Pharmaceutical Industry. New Plant on Its Mourenx, France Site, to Produce a Large Volume Commercial API". Pompey. 2012-10-10
Cellectis S.A.. (10/8/12). "Press Release: Cellectis – the Award of Nobel Prize in Medicine to Professor Yamanaka Confirms the Relevance of the Group’s Stem Cell Strategy". Paris. 2012-10-08
Novasep S.A.. (10/2/12). "Press Release: Change to Novasep Governance. Roger-Marc Nicoud Becomes Non-executive Chairman of the Board – Patrick Glaser, Head of Novasep Synthesis, Is Appointed President and CEO". Pompey. 2012-10-02
Servier. (10/1/12). "Press Release: Servier Concludes a Collaboration and License Agreement with EOS for Its Antitumor Drug E-3810". Suresnes & Milano. 2012-10-01
PX’Therapeutics S.A.. (10/1/12). "Press Release: Aguettant, an Independent French Pharmaceutical Company, and PX'Therapeutics, a French Contract Manufacturing Organization Dedicated to the Development of Recombinant Proteins, Join Forces to Boost Their A 2012-10-01
Trophos S.A.. (9/18/12). "Press Release: Marceline Clementine Appointed Chief Financial Officer". Marseille. 2012-09-18
Oncodesign S.A.. (9/13/12). "Press Release: Oncodesign Enters into a Research Collaboration and License Agreement with Sanofi for the Application of Oncodesign’s Nanocyclix Technology to Sanofi’s Kinase Targets". Dijon. 2012-09-13
Theravectys S.A.. (9/4/12). "Press Release: Theravectys Raises 7.48 Million Euros, One of the Largest Fundings in Private Equity in 2012". Paris. 2012-09-04
Hybrigenics S.A.. (8/28/12). "Press Release: Hybrigenics Books an Exceptional Revenue of EUR 1 Million. Part of Redeemable Advance from the French Ministry of Industry to Perform Protein Interaction Research Is Requalified as a Grant". Paris. 2012-08-28
Vivalis S.A.. (8/28/12). "Press Release: Vivalis Announces a New EB66 Cell Line Research License Agreement with BioFactura". Nantes & Lyon. 2012-08-28
Ipsen S.A.. (8/21/12). "Press Release: Ipsen and Inspiration Biopharmaceuticals Renegotiate Strategic Partnership Agreement. Ipsen Gains Commercial Rights in Key Territories". Paris. 2012-08-21
Vivalis S.A.. (8/21/12). "Press Release: Successful Growth of BioDiem’s Virus in Vivalis EB66 Cell Line". Melbourne & Nantes. 2012-08-21
Sanofi S.A.. (8/3/12). "Press Release: U.S. FDA Approves Zaltrap (ziv-aflibercept) after Priority Review for Previously Treated Metastatic Colorectal Cancer". Paris & Tarrytown, NY. 2012-08-03
Trophos S.A.. (7/31/12). "Press Release: Trophos Announces Conclusion of MitoTarget Consortium, Achieving Advanced Understanding of Neurodegenerative Diseases". Marseille. 2012-07-31
Nicox S.A.. (7/27/12). "Press Release: NicOx First Half 2012 Financial Results". Sophia Antipolis. 2012-07-27
Sanofi S.A.. (7/26/12). "Press Release: As Expected, Q2 2012 Business EPS Impacted by the Loss of Exclusivity of Plavix and Avapro in the U.S.". 2012-07-26
Trophos S.A.. (7/23/12). "Press Release: Trophos Appoints JSB Partners as Global Partnership Advisor. Life Science Advisor to Advise Trophos on Strategic Partnerships for Orphan Disease and Niche Indication Candidates". Marseille. 2012-07-23
Novasep S.A.. (7/19/12). "Press Release: Novasep Invests 3 Million Euros to Boost Its HPAPI Manufacturing Capabilities". Pompey. 2012-07-19
Hybrigenics S.A.. (7/18/12). "Press Release: Hybrigenics’ First Half 2012 Revenues of EUR 2 Million Are at the Same Level as in 2011". Paris. 2012-07-18
Domain Therapeutics S.A.. (7/17/12). "Press Release: Domain Therapeutics Closes 2 Million Euros Funding Round". Strasbourg. 2012-07-17
Exonhit S.A.. (7/16/12). "Press Release: Alzheimer’s Disease. Patient Enrollment Completed ahead of Plan in Exonhit’s Studies in AclarusDx". Paris. 2012-07-16
Bayer AG. (7/12/12). "Press Release: Kogenate Bayer Was Effective in Reducing Bleeding Frequency when Used as Secondary Prophylaxis in Adults with Severe Hemophilia A [Not intended for U.S. and UK Media]". Berlin. 2012-07-12
Edmond de Rothschild Investment Partners. (7/10/12). "Press Release: First Closing and Launch of BioDiscovery 4". 2012-07-10
Calixar S.A.S.. (7/5/12). "Press Release: Calixar and Synthelis Team Up to Provide Unique Membrane Protein Services". Lyon & Grenoble. 2012-07-05
Cytoo S.A.. (7/5/12). "Press Release: Cytoo and PharmaNest Are Launching the New 2D+ Cell Culture Platform". Grenoble. 2012-07-05
Bayer AG. (7/2/12). "Press Release: Bayer to Present Data Hemophilia Research at the WFH 2012 World Congress. SPINART Phase III Clinical Data – BAY 94-9027 Phase I Clinical Trial Data". Berlin. 2012-07-02
Medigene AG. (7/2/12). "Press Release: Medigene’s Veregen Receives Marketing Authorization in France. Market Launch in France Expected in 2013". Martinsried/Munich. 2012-07-02
Imaxio S.A.. (6/27/12). "Press Release: Imaxio Boosts Genomics Capacity with New Automated Equipment. Investment Means Larger Scale, Faster High Throughput Sequencing for Imaxio Customers". Clermont-Ferrand. 2012-06-27
Theradiag S.A.. (6/27/12). "Press Release: Theradiag Acquires Prestizia and Its Highly Innovative microRNA Technology Platform". 2012-06-27
Vivalis S.A.. (6/20/12). "Press Release: Vivalis Announces a New EB66 Cell Line Commercial License Agreement with Farvet Farmacológicos Veterinarios". 2012-06-20
ImaBiotech S.A.S.. (6/20/12). "Press Release: ImaBiotech Initiates a Long-term Collaboration with Genfit". Lille. 2012-06-20
Calixar S.A.S.. (6/18/12). "Press Release: Calixar Closes an Initial 875,000 Euro Funding Round. The Funds Will Enable the Lyon-based Membrane Protein Services Specialist to Develop Its International Business". Lyon. 2012-06-18
Lysogene. (6/14/12). "Press Release: Complete Enrollment in PI-SAF-301 Clinical Trial". 2012-06-14
Cytheris S.A.. (6/12/12). "Press Release: Cytheris SA Appoints Damian Marron as Chief Executive Officer". Paris. 2012-06-12
ProTip S.A.. (6/7/12). "Press Release: ProTip Medical Closes USD 4.7 (EUR 3.8) Million Financing Round. Funds Will Advance Clinical Development of ProTip’s ENTegral". Strasbourg. 2012-06-07
Exonhit S.A.. (6/5/12). "Press Release: Exonhit Receives € 1.93 Million from OSEO within the Personalized Medicine TEDAC Project in Cancer. Financing of € 1,928,000 through both Grants and Redeemable Advances". Paris. 2012-06-05
Hybrigenics S.A.. (6/4/12). "Press Release: Hybrigenics Reports Initial Results from Clinical Phase 2 Trial of Oral Inecalcitol in Moderate to Severe Psoriasis". Paris. 2012-06-04
Alizé Pharma. (6/4/12). "Press Release: Alizé Pharma Closes 3.3 Million Euro Funding Round". Lyon. 2012-06-04
Cellectis S.A.. (5/21/12). "Press Release: Cellectis Stem Cells Today Proudly Announces the Launch of the World’s Very First Human iPS Cell-derived Hepatocyte Product". Gothenburg. 2012-05-21
Genfit. (5/2/12). "Press Release: Reserved Capital Increase. YA Global Master SPV Ltd, Managed by the Investment Company Yorkville Advisors LLC, Invests a Further €600 K". Lille & Cambridge, MA. 2012-05-02
Theradiag S.A.. (5/2/12). "Press Release: Biomedical Diagnostics (BMD) Becomes Theradiag and Moves into Theranostics". Paris. 2012-05-02
Genfit. (4/25/12). "Press Release: Annual Results for 2011". Lille & Cambridge, MA. 2012-04-25
Nanobiotix. (4/24/12). "Press Release: Nanobiotix Appoints Bernd Mühlenweg as a Member of the Executive Board". Paris. 2012-04-24
Novasep S.A.. (4/23/12). "Press Release: Novasep Strenghtens Its Management Team with the Appointment of Jean-Claude Romain as Corporate Quality Director and Alain Lamproye as Director of Novasep Bioproduction Site in Belgium". Pompey. 2012-04-23
Immutep S.A.. (4/10/12). "Press Release: Immutep and Lonza Sign Agreement for Cell Line Selection, Cell Banking and Process Development of ImmuFact IMP321". Basel & Orsay. 2012-04-10
Cellectis S.A.. (4/2/12). "Press Release: Appointment of Mathieu Simon, MD, to the Position of Senior Vice President of Cellectis Group". Paris. 2012-04-02
Vivalis S.A.. (3/29/12). "Press Release: Vivalis 2011 Results. Continuing Growth Momentum". Nantes & Lyon. 2012-03-29
Omnes Capital S.A.S.. (3/29/12). "Press Release: Crédit Agricole Private Equity Becomes Omnes Capital". 2012-03-29
Novasep S.A.. (3/27/12). "Press Release: Novasep Opens New 2,000 m² Expanded Shanghai Facilities to Meet Increasing East Asia Demand". Pompey & Shanghai. 2012-03-27
Hybrigenics S.A.. (3/27/12). "Press Release: Hybrigenics Completed Its Private Placement to Institutional Investors up to EUR 3.3 Million". Paris. 2012-03-27
Cellectis S.A.. (3/23/12). "Press Release: 2011 Full-year Earnings. Growth Strategy Stepped Up – 22% Sales Growth". Paris. 2012-03-23
Enterome Bioscience S.A.. (3/22/12). "Press Release: Enterome Raises EUR Five Million in Series A Funding Round. Funding Enables further Development of Unique Metagenomic Technology and Solutions for Gut Microbiota-related Diseases Affecting a Large Prop 2012-03-22
Novasep S.A.. (3/21/12). "Press Release: Novasep Announces Major Recapitalization to Boost Its Growth. A Strongly Improved Balance Sheet, New Shareholders and an Entrepreneurial Management to Support the Group’s Development Going Forward". Pompey. 2012-03-21
Nicox S.A.. (3/21/12). "Press Release: NicOx Enters into Option Agreement to Acquire Altacor as a First Step Towards Building an International Ophthalmology Business". Sophia Antipolis. 2012-03-21
Adocia S.A.. (3/15/12). "Press Release: Adocia Increase the Size of Its Initial Public Offering to €27.4 Million through the Partial Exercise of the Overallotment Option [Not to Be Published in United States of America, Canada, Australia , Italy or Japan 2012-03-15
Vivalis S.A.. (3/13/12). "Press Release: Vivalis Announces the Signature of a Broad Collaboration Agreement and Commercial License for the Use of the EB66 Cell Line for the Production of a Monoclonal Antibody". Nantes & Lyon. 2012-03-13
IntegraGen S.A.. (3/6/12). "Press Release: 45% Growth of Genomic Services in 2011 – IntegraGen Becomes the First French Services Lab Equipped with an Illumina MiSeq". Evry. 2012-03-06
Exonhit S.A.. (3/5/12). "Press Release: Exonhit Is Beneficiary of a Grant from the European Union within the RESPONSIFY Consortium. € 418,000 Grant – European Personalized Medicine Consortium with 12 Partners". Paris. 2012-03-05
Adocia S.A.. (2/14/12). "Press Release: Adocia Carris Out, with much Success, the First IPO of the Year on the NYSE Euronext Paris Regulated Market [This document may not be published, distributed or disseminated, directly or indirectly, in the United St 2012-02-14
Alizé Pharma. (2/2/12). "Press Release: Alizé Pharma Licenses Its Asparec Therapy for Treatment of Acute Lymphoblastic Leukemia (ALL) to EUSA Pharma". Lyon. 2012-02-02
Hybrigenics S.A.. (1/30/12). "Press Release: Hybrigenics Revenues Grew 45% to EUR 6.6 Million in 2011. Hybrigenics Services Contributed for EUR 4.1 Million, a 17% Growth". Paris. 2012-01-30
Domain Therapeutics S.A.. (1/30/12). "Press Release: Domain Therapeutics Awarded Grant from The Michael J. Fox Foundation for the Development of Novel mGluR3 PAM Compounds to Treat Parkinson’s Disease". Strasbourg. 2012-01-30
Stentys S.A.. (1/25/12). "Press Release: Stentys Launches a Private Placement of Up to 10% of Capital". Paris. 2012-01-25
Vivalis S.A.. (1/24/12). "Press Release: Strong Revenue Growth – +112%. Initation of a Third Antibody Discovery Program with Sanofi Pasteur". Nantes & Lyon. 2012-01-24
Vivalis S.A.. (1/23/12). "Press Release: Opening of a New Laboratory Dedicated to the Viva|Screen Antibody Discovery Platform". Nantes, Lyon & Toyama. 2012-01-23
Hybrigenics S.A.. (1/19/12). "Press Release: Hybrigenics Targets Chronic Lymphocytic Leukemia (CLL) as the Third Therapeutic Indication for Its Oral Inecalcitol". Paris. 2012-01-19
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top